STOCK TITAN

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Champions Oncology, Inc. (CSBR) will report its second quarter financial results for the period ended October 31, 2022, on December 13, 2022, after market close. The company specializes in drug discovery through AI-driven pharmaco-pheno-multiomic integration and offers innovative research services to biopharma organizations. A conference call discussing the results will take place at 4:30 PM EST on the same day, with dial-in options available for both domestic and international participants. A replay will be accessible within 72 hours.

Positive
  • Champions Oncology is known for its innovative approach in drug discovery.
  • The company provides valuable research software and R&D services to biopharma organizations.
Negative
  • None.

HACKENSACK, NJ / ACCESSWIRE / December 9, 2022 / Champions Oncology, Inc. (CSBR), a leading global technology-enabled biotech that is transforming drug discovery through innovative AI-driven pharmaco-pheno-multiomic integration, will report its financial and operational results for the second quarter ended October 31, 2022, on Tuesday, December 13, 2022, after market close. The company will host a conference call to discuss the results that day at 4:30 P.M. EST (1:30 P.M. PST). To join the call dial 877-545-0523 (Domestic) or 973-528-0016 (International) and enter the access code 541646. A replay of the call will be available by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) and entering passcode: 47307, or by accessing the investors section of the company's website within 72 hours.

About Champions Oncology, Inc.

Champions Oncology is a technology-driven research organization that develops innovative therapeutics against cancer targets, offers groundbreaking research software as a service, and provides end-to-end R&D services to biopharma organizations. Champions Oncology is actively engaged in the transformation of drug discovery through a novel approach of pharmaco-pheno-multiomic integration. For more information, please visit www.ChampionsOncology.com.

SOURCE: Champions Oncology, Inc.



View source version on accesswire.com:
https://www.accesswire.com/731165/Champions-Oncology-to-Announce-Second-Quarter-Financial-Results-on-Tuesday-December-13-2022

FAQ

When will Champions Oncology report its Q2 financial results?

Champions Oncology will report its Q2 financial results on December 13, 2022, after market close.

What time is the Champions Oncology conference call?

The Champions Oncology conference call is scheduled for 4:30 PM EST on December 13, 2022.

What is the stock symbol for Champions Oncology?

The stock symbol for Champions Oncology is CSBR.

How can I access the replay of the conference call?

The replay of the conference call can be accessed by dialing 877-481-4010 (Domestic) or 919-882-2331 (International) using passcode 47307, or via the investors section of the company's website within 72 hours.

Champions Oncology, Inc.

NASDAQ:CSBR

CSBR Rankings

CSBR Latest News

CSBR Stock Data

98.08M
10.01M
26.33%
49.09%
1.65%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BALTIMORE